Kuros Biosciences (Kuros), a global leader in advanced bone healing technologies, has expanded into the extremities markets with the appointment of Jantzen Cole as Vice President of Market Development, Extremities, and the formation of a dedicated Surgeon Advisory Board (SAB). 

Under Cole’s leadership, Kuros will leverage its existing hospital approvals and established infrastructure, building on the company’s proven success in the spine market. 

Cole has over two decades of experience in the orthopedic and medical fields. Most recently, he served as Vice President of Marketing at Artelon, where he drove notable revenue growth and brand recognition in the ankle instability market leading up to the recent acquisition by Stryker.

With three MagnetOs formulations indicated for use beyond spine procedures, this expansion opens a market opportunity with a total addressable market estimated at $1 billion. Supported by robust scientific, pre-clinical, and clinical evidence, ideal handling characteristics, and a strong safety profile, MagnetOs is well positioned to address the need for improved fusion outcomes in extremities markets. 

“We are thrilled to welcome Jantzen to the Kuros team. His extensive F&A expertise and proven success in launching transformative medical technologies align seamlessly with our vision,” said Chris Fair, Chief Executive Officer of Kuros Biosciences. “With our robust clinical data and support of our newly founded SAB, Kuros is well-positioned to expand globally beyond spine.”

Kuros has also initiated an SAB of renowned experts to offer insights and guidance for the introduction of MagnetOs in the extremities markets. The initial board members include Greg Berlet, MD, FAOA, FRCS(C), Orthopedic Foot & Ankle Center, Westerville, Ohio; Peter Mangone, MD, FAAOS, Chief of Foot & Ankle Surgery, University of Pittsburgh Medical Center (UPMC), PA; and Carlos Sagebien, MD, FAAOS, Clinical Assistant Professor of Orthopaedics, Robert Wood Johnson University Hospital, New Brunswick, NJ.

The development of this specialized advisory board will be instrumental in defining clinical applications and commercial strategies to meet patient, surgeon, and hospital needs.

MagnetOs technology will be introduced to foot and ankle surgeons at the Foot Innovate platform on Thursday, November 21. Dr. Greg Berlet and Dr. Katherine Sage, Kuros Senior Vice President of Medical and Clinical Affairs, will lead the introduction.